FY2025 EPS Estimates for TSE:CPH Lowered by Leede Financial

Cipher Pharmaceuticals Inc. (TSE:CPH) (NASDAQ:CPHR) – Leede Financial lowered their FY2025 earnings per share (EPS) estimates for shares of Cipher Pharmaceuticals in a research report issued on Wednesday, March 19th. Leede Financial analyst D. Loe now anticipates that the company will post earnings per share of $0.87 for the year, down from their previous forecast of $0.93. The consensus estimate for Cipher Pharmaceuticals’ current full-year earnings is $1.29 per share. Leede Financial also issued estimates for Cipher Pharmaceuticals’ FY2026 earnings at $1.00 EPS.

Cipher Pharmaceuticals Stock Performance

TSE CPH opened at C$13.14 on Friday. Cipher Pharmaceuticals has a 1-year low of C$7.90 and a 1-year high of C$19.69. The company has a market capitalization of C$235.91 million, a P/E ratio of 14.51 and a beta of 1.20. The business has a 50 day moving average price of C$12.91 and a 200 day moving average price of C$14.52. The company has a debt-to-equity ratio of 41.22, a current ratio of 2.00 and a quick ratio of 2.67.

About Cipher Pharmaceuticals

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company’s geographical segments include Canada and the United States.